VERTEX PHARMACEUTICALS INCORPORATED
Registrant: STANTON PARK GROUP
2nd Quarter (Apr 1 - June 30)
Jul 20, 2026
Reported lobbying issue
Health Issues: Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; HR 1227 and S. 375
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $50,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗VERTEX PHARMACEUTICALS INCORPORATED
Registrant: EMPIRE CONSULTING GROUP
2nd Quarter (Apr 1 - June 30)
Jul 16, 2026
Reported lobbying issue
Health Issues: Issues related to HR 1227, Alternatives to Pain Act
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $50,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗VERTEX PHARMACEUTICALS INCORPORATED
Registrant: STANTON PARK GROUP
1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026
Reported lobbying issue
Health Issues: Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; HR 1227 and S. 375
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $50,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗VERTEX PHARMACEUTICALS INCORPORATED
Registrant: EMPIRE CONSULTING GROUP
1st Quarter (Jan 1 - Mar 31)
Apr 18, 2026
Reported lobbying issue
Health Issues: HR 1227, Alternatives to PAIN Act.
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $50,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗VERTEX PHARMACEUTICALS INCORPORATED
Registrant: EMPIRE CONSULTING GROUP
4th Quarter (Oct 1 - Dec 31)
Jan 19, 2026
Reported lobbying issue
Health Issues: HR 1227, Alternatives to PAIN Act.
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $30,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗VERTEX PHARMACEUTICALS INCORPORATED
Registrant: EMPIRE CONSULTING GROUP
3rd Quarter (July 1 - Sep 30)
Oct 19, 2025
Reported lobbying issue
Health Issues: HR 1227, Alternatives to PAIN Act.
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $30,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗VERTEX PHARMACEUTICALS INCORPORATED
Registrant: EMPIRE CONSULTING GROUP
2nd Quarter (Apr 1 - June 30)
Jul 18, 2025
Reported lobbying issue
Health Issues: HR 1227, Alternatives to PAIN Act.
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $40,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗VERTEX PHARMACEUTICALS INCORPORATED
Registrant: EMPIRE CONSULTING GROUP
1st Quarter (Jan 1 - Mar 31)
Apr 18, 2025
Reported lobbying issue
Health Issues: HR 1227, Alternatives to PAIN Act; issues related to CMMIs Cell and Gene Therapy Access model for Sickle Cell Disease.
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $50,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗VERTEX PHARMACEUTICALS INCORPORATED
Registrant: AVENUE SOLUTIONS
2nd Quarter (Apr 1 - June 30)
Jul 20, 2026
Reported lobbying issue
Medicare/Medicaid: H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; Kidney care issues; FY27 LHHS and Mil-Con appropriations report language
Health Issues: Monitor issues related to 340b;
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $60,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗AMERICAN ASSOCIATION OF NURSE PRACTITIONERS
Registrant: AMERICAN ASSOCIATION OF NURSE PRACTITIONERS
2nd Quarter (Apr 1 - June 30)
Jul 20, 2026
Reported lobbying issue
Health Issues: H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act S. 1599/H.R. 6394 - Midwives for Maximizing Optimal Maternity Services (MOMS) Act S. 131/H.R. 392 - Providing Real-world Education and Clinical Experience by Precepting Tomorrows (PRECEPT) Nurses Act H.R. 4564 - Dillons Law H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 3435/H.R. 6607 - Future Advancement of Academic Nursing (FAAN) Act H.R. 1627 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 2319/S. 1157 - the Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1261/H.R. 4206 - CONNECT for Health Act for 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act (Restore Act) H.Res. 389/S.Res. 206 - Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2025. S. 1482/H.R. 4407 - National Nursing Workforce Center Act of 2025 H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 1300 - Prostate-Specific Antigen (PSA) Screening for High-risk Insured Men (HIM) Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 5629 - To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect. H.R. 7787 - Mental Health Workforce Act S. 4186/H.R. 8089 - Perinatal Workforce Act H.R. 7973 - Momnibus Act S. 3707/H.R. 7279 - Nurse Faculty Shortage Reduction Act. H.R. 7602 - State of Men's Health Act H.Res. 1264/S.Res. 709 - Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2026. H.R. 8163 - the Provider Reimbursement Stability Act H.R. 8261 - Chronic Care Management Improvement Act Affordability of health insurance coverage Tobacco prevention Hospice certification and recertification Immunization policies H.R. 9257/S. 4754 - Primary and Behavioral Health Care Access Act Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Health plan coverage and program requirements, including provider non-discrimination, network adequacy and prior authorization Nursing faculty and workforce shortage Nursing education Include nurses, APRNs, and nursing students in all national public health plans Rural health care issues, including rural workforce and reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic Use of telehealth to prescribe controlled substances under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 [Public Law No: 110-425] Site specific restrictions on providers under DEA controlled substances policy Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records
Budget/Appropriations: Appropriations Act, 2027 H.R. 7148 - Consolidated Appropriations Act, 2026 [P.L. No. 119-75] H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Funding for Fiscal Year 2027 for Title VIII Nursing Workforce Development Programs Funding for Fiscal Year 2027 for the National Institute of Nursing Research H.R. 5371 - Continuing Appropriations and Extensions Act, 2026 S. 2882 - Continuing Appropriations and Extensions and Other Matters Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] implementation and federal student loan limits Funding for Fiscal Year 2026 for Title VIII Nursing Workforce Development Programs Funding for Fiscal Year 2026 for the National Institute of Nursing Research H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Supporting nursing as a professional degree Issues pertaining to the Department of Education proposal for the professional degree designation of federal student loans Funding for DCD Environmental Health Laboratory for childrens health Support funding for the National Health Service Corps Removal of burdensome Medicare requirements pertaining to nurse practitioners
Government Issues: H.R. 4122/S. 2167 - Health Care for Energy Workers Act H.R. 3170/S. 3296 - The Improving Access to Workers Compensation for Injured Federal Workers Act H.R. 2332/S. 1101 - States Handling Access to Reciprocity for Employment (SHARE) Act. Provider neutral language in federal forms, documents and surveys
Medicare/Medicaid: H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 1261/H.R. 4206 - CONNECT for Health Act of 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 7787 - Mental Health Workforce Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 7973 - Momnibus Act H.R. 8163 - the Provider Reimbursement Stability Act Hospice certification and recertification Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic
Veterans: H.R. 2234 - Ensuring Veterans Timely Access to Anesthesia Care Act S. 3329/H.R. 6203 - U.S. Cadet Nurse Corps Service Recognition Act of 2025 Advanced Practice Nursing full practice authority in the Veterans Health Administration Use of non-opioid therapies in the VA
Taxation/Internal Revenue Code: H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 3145/S. 1548 - Nurse Corp Tax Parity Act Taxation of non-profit organizations
Education: H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 S. 4568/H.R. 8691 - Nursing is a Professional Degree Act H.R. 6718 - Professional Student Degree Act H.J. Res. 189 / S.J. Res. 196 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Education relating to "Reimagining and Improving Student Education-Federal Student Loan Program Final Regulations"
Defense: H.J.Res.149 - Recognizing the 125th anniversary of the Army Nurse Corps, expressing gratitude for members of the Army Nurse Corps for their service to the Nation, and for other purposes. S.Con.Res.27 - A concurrent resolution celebrating the 125th Anniversary of the Army Nurse Corps H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027 H.R. 3170/S. 3296 - Improving Access to Workers Compensation for Injured Federal Workers Act
Labor Issues/Antitrust/Workplace: H.R. 8272 - To classify qualified locum tenens professionals and advanced care practitioners as independent contractors for the purposes of the Fair Labor Standards Act of 1938 and the National Labor Relations Act.
Government entities reported: Centers For Medicare and Medicaid Services (CMS)
Drug Enforcement Administration (DEA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
White House Office
Labor, Dept of (DOL)
Veterans Affairs, Dept of (VA)
Education, Dept of
Office of Management & Budget (OMB)
Reported filing-period amount: $400,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗AMERICAN PSYCHIATRIC ASSOCIATION
Registrant: AMERICAN PSYCHIATRIC ASSOCIATION
2nd Quarter (Apr 1 - June 30)
Jul 20, 2026
Reported lobbying issue
Medical/Disease Research/Clinical Labs: APA response to NIH-Wide strategic plan framework for fiscal years 2027-2031
Budget/Appropriations: Fiscal Year 2027 (FY2027) Departments of Labor, Health and Human Services, Education, and Related Agencies appropriations bill Response to OMB proposed rule, Regulation for Federal Financial Assistance
Health Issues: H.R. 929/S.266 - Lorna Breen Health Care Provider Protection Reauthorization H.R. 593 - Strengthening Pathways to Health Professions Act H.R. 879/S.1640 - Medicare Patient Access and Practice Stabilization Act H.R. 1153 - Rural America Health Corps Act H.R. 1227/S.475 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 1735/S.779 - EARLY Minds Act H.R. 1448 - PEER for Mental Health Act H.R. 1585/S.709 - Conrad State 30 and Physician Access Reauthorization Act H.R. 1909/S.2621 - Preventing Maternal Deaths Reauthorization Act of 2025 H.R. 957 - Parity Enforcement Act H.R. 2509/S.931 - COMPLETE Care Act H.R. 4206/S.1261 - CONNECT for Health Act H.R. 1305 - Improving Measurements for Loneliness and Isolation Act H.R. 1902 - Helping Emergency Responders Overcome (HERO) Act H.R. 2223 - Building Capacity for Care Act H.R. 2586 - Reentry Act of 2025 H.R. 3884/S.2011 - Telemental Health Care Access Act of 2025 H.R. 3266/S.1673 - Mental Health Infrastructure Improvement Act of 2025 H.R. 4619 - Medicare Mental Health Inpatient Equity Act S. 1062 - Suicide Prevention Act H.R. 912 - 9-8-8 Lifeline Cybersecurity Act H.R. 2587 - Youth Mental Health Research Act H.R. 2483/S.2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 2630 - Youth Suicide Prevention Research Act H.R. 3655 - STAR Plus Scholarship Act H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025 H.R. 3885/S.3989 - Community TEAMS Act H.R. 1867 - To amend title XVIII of the Social Security Act to remove in-person requirements under Medicare for mental health services furnished through telehealth and telecommunications technology H.R. 3164 - Ensuring Community Access to Pharmacist Services (ECAPS) Act H.R. 4681/S. 1379 - Specialty Physicians Advancing Rural Care (SPARC) Act H.R. 4723/S. 2446 - Mental Health for Latinos Act Conversations with Congressional offices on Teaching Health Center Graduate Medical Education (THCGME) H.R.3505 - Barriers to Suicide Act H.R.6249 - Addressing Addiction After Disasters Act H.R.7394/S.3783 - Mental Health Career Promotion Act H.R. 5074 - Protecting Young Minds Online Act H.R. 5434/S. 2826 - 988 LGBTQ+ Youth Access Act H.R.5509 /S.2903 - Safe Step Act H.R. 5557 - Mental Health Services for Students Act H.R.1197 - PREEMIE Reauthorization Act of 2025 H.R. 3514/S.1816 - Improving Seniors Timely Access to Care Act H.Res.792 - Youth Mental Health Day and Suicide Prevention Day Resolution H.R.5725 - Mental Health Crisis Response Act of 2025 H.R.5706 - Mental Health Emergency Responder Act S. 3064 - Relief of Chronic Pain Act H.R. 6226 - Latino Youth Mental Health Empowerment Act H.R. 5482 - Prevent Youth Suicide Act H.R.6672 - Mental Health Professionals Workforce Shortage Loan Repayment Act Letter to Letter to Department of Labor, Department of Health and Human Services, and Department of Treasury regarding mental health parity enforcement H.R. 3492 - Protect Children's Innocence Act H.R. 498 - Do No Harm in Medicaid Act H.R. 6817/ S. 1056 - Home-Based Telemental Health Care Act Communication with Congressional offices on SAMHSA grant terminations Input on Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) modernization Communication with Congressional offices on ghost networks S. 3486 - Expand the Behavioral Health Workforce Now Act H.R.7324/S. 683 - More Behavioral Health Providers Act H.R. 786/S. 1460 - Preserving Patient Access to Accountable Care Act H.R. 4331 - Access to Claims Data Act H.R.5281 - REAL Health Providers Act H.R.7875 - Providing Opportunities for Individuals in Need of Treatment and Support (POINTS) Act Letter to Congress on Agency for Healthcare Research and Quality (AHRQ) funding H.R. 6396 - Kid PROOF Act H.R. 6468 - Rural Residency Planning and Development Act of 2025 H.R. 8234 - Save Money, Save Lives Act H.R.7092 - RAYS Act H.R.7787 - Mental Health Workforce Act Letter in support of funding for gun violence prevention research at CDC, NIH and NIJ. S.4076 - Removing Medicare Mental Health Inpatient Limitations Act of 2026 Letter supporting funding for Maternal Mental Health and Substance Use Disorder Programs (MMHSUD) and National Maternal Mental Health Hotline. H.R. 5629 - To provide that the final rule of the Department of Health and Human Services titled Medications for the Treatment of Opioid Use Disorder except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect H.R. 7994 - The HERO Act H.R. 8124 - STOP Suicide Act S.1924 / H.R.3624 - Improving Mental Health Access for Students Act H.R.8261 - Chronic Care Management Act Letter in support of funding for the Pediatric Mental Health Care Access program H.R. 8201 - Expanding Community Access to Health Services Act Letter supporting increased funding for Childrens Hospital Graduate Medical Education Letter expressing concerns over H.R. 5629 and H.R. 5630 S. 1874 - Title VIII Nursing Workforce Reauthorization Act of 2025 S. 4110 - EMPOWER for Health Act H.R. 9044 - Minority Fellowship Program Reauthorization Act of 2026 H.R. 8163 - Provider Reimbursement Stability Act H.R.8961 - Student Suicide Prevention Awareness Act H.Res.1329 - Expressing support for the designation of May 2026 as Mental Health Awareness Month H.R.8989 - Evidence-Based Youth Suicide Prevention Act of 2026 H.R.8122/ S.4640 - 9-8-8 Connect Act H.R.8811/S.4552 - Moms Matter Act H.R.9257 - Primary and Behavioral Health Care Access Act H.R.8487/S.3401 - Ensuring Excellence in Mental Health Act Joint letter to SAMHSA regarding the planned removal of SAMHSAs buprenorphine practitioner locator and pharmacy locator.
Veterans: H.R. 1107 - Protecting Veteran Access to Telemedicine Services Act H.R. 1987/ S. 926 - Saving Our Veterans Lives Act Support for VA physician exemptions to return to office H.R. 3863 - VA Mental Health Outreach and Engagement Act H.R. 4837 - Written Informed Consent Act H.R.8044 - Get Justice-Involved Veterans Behavioral Assistance and Care for Key Health Outcomes to Maintain Empowerment (BACK HOME) Act
Medicare/Medicaid: Letter to CMS outlining recommendations for the Medicaid Community Engagement Provisions of H.R.1 Letter to CMS regarding Medicaid and CHIP funding for gender affirming care proposed rule Letter to CMS regarding conditions of participation for gender affirming care proposed rule Response to CMS Medicare Advantage and Medicare Part D 2027 proposed rule Letter to CMS regarding hospital signage guidance Letter to CMS regarding Patient Protection and Affordable Care Act Benefit and Payment Parameters 2027 proposed rule Letter to CMS regarding support for Suicide Safety Planning, and The Collaborative Care Model Letter to CMS in response to RFI on Step Therapy Letter to CMS regarding Interoperability Standards and Prior Authorization proposed rule Letter to CMS regarding Hospital Inpatient Prospective Payment System and Quality Reporting Program 2027 proposed rule Letter to CMS regarding Inpatient Psychiatric Facility Quality Reporting Program and Prospective Payment System 2027 proposed rule Joint letter to HHS, Treasury, and Labor regarding implementation and CMS enforcement of the No Surprises Act Coalition letter to Senator Cassidy, Senator Smith, Representative Tonko, and Representative Huizenga regarding support of Removing Medicare Mental Health Inpatient Limitations Act (S.4076) and the Medicare Mental Health Inpatient Equity Act (H.R. 4619) Joint communication to CMS regarding the implementation of Medicaid eligibility and community engagement requirements under H.R. 1.
Education: H.R. 2028/ S. 942 - Resident Education Deferred Interest Act (REDI Act) Letter supporting funding for Mental Health Services Professional Demonstration (MHSP) and School-Based Mental Health Services (SBMH) grant programs
Immigration: Letter to DHS Secretary regarding physician J-1 visas Letter to DHS Secretary for physician exemption to H-1B visa fee H.R. 7961 - H-1Bs for Physicians and the Healthcare Workforce Act
Government entities reported: Natl Institutes of Health (NIH)
Executive Office of the President (EOP)
HOUSE OF REPRESENTATIVES
Office of Management & Budget (OMB)
SENATE
Health & Human Services, Dept of (HHS)
Labor, Dept of (DOL)
Substance Abuse & Mental Health Services Administration (SAMHSA)
Treasury, Dept of
Veterans Affairs, Dept of (VA)
Centers For Medicare and Medicaid Services (CMS)
Education, Dept of
Homeland Security, Dept of (DHS)
Reported filing-period amount: $137,391
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗VERTEX PHARMACEUTICALS INCORPORATED
Registrant: CGCN GROUP, LLC
2nd Quarter (Apr 1 - June 30)
Jul 19, 2026
Reported lobbying issue
Health Issues: Access to innovative non-opioid medicines.
Medicare/Medicaid: Access to innovative non-opioid medicines; Alternatives to PAIN, H.R. 1227; Alternatives to PAIN, S. 475.
Government entities reported: Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
White House Office
Reported filing-period amount: $50,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗VERTEX PHARMACEUTICALS
Registrant: TIBER CREEK GROUP
2nd Quarter (Apr 1 - June 30)
Jul 18, 2026
Reported lobbying issue
Health Issues: Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.
Defense: Issues related to coverage of opioid alternatives.
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $60,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗AMERICAN SOCIETY OF ANESTHESIOLOGISTS
Registrant: AMERICAN SOCIETY OF ANESTHESIOLOGISTS
2nd Quarter (Apr 1 - June 30)
Jul 17, 2026
Reported lobbying issue
Medicare/Medicaid: H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025: payment rates H.R. 1317 (2025-2026), I CAN Act: provision of service under Medicare Medicare sequester, PAYGO Medicare Advantage Upcoding Medicare for All/Public Option Historical Medicare payment undervaluation for anesthesiology services (33% problem) Anesthesia Conversion Factor Medicare Physician Fee Schedule Rule Budget neutrality Medicare Economic Index: Medicare inflationary increase Medicaid Bundled payments H.R. 5454/S. 2879 Medicare Advantage Prompt Pay Act WISeR Model Medicare Administrative Contractor (MAC) Local Coverage Determinations (LCD) Practice Expense (PE) Opioid sparing Labor, Health and Human Services (LHHS) Appropriation S.586 - NOPAIN Act: Non-Opioids Prevent Addiction In the Nation Act or the NOPAIN Act
Health Issues: Graduate Medical Education Certified Anesthesiologist Assistants Anesthesia workforce shortages HR 3890, Resident Physician Shortage Reduction Act of 2025: residency positions S.709, Conrad State 30 and Physician Access Reauthorization Act: Foreign physician immigration status S. 1380, Specialty Physicians Advancing Rural Care (SPARC) Act: physician shortages in rural areas HR 2028; Resident Education Deferred Interest Act (REDI Act): Student loan relief Anesthesia Research Funding Scope of Practice Merit-based Incentive Payment System, MIPS, MIPS Value Pathway Quality Payment Program, QPP Alternative Payment Model, APM QCDR - Qualified Clinical Data Registry Evaluation and Monitoring codes & cuts Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Brain health CMS Interpretive Guidelines: Hospital Conditions of Participation Related to Anesthesia Services Conditions of Participation - Anesthesia services, opt-outs, supervision CMS: Federal Independent Dispute Resolution (IDR) Process, Batching H.R.27, HALT Fentanyl Act: fentanyl scheduling and registration requirements H.R. 1227/S.475, Alternatives to PAIN Act of 2025: access to non-opioid pain management options Pain Medicine Prescription Drug Abuse CDC Opioid Prescribing Guideline H.R. 3595, Safe Prescribing Through Reporting Act of 2025: disclosure of certain records relating to substance use disorder medications to State prescription drug monitoring programs Drug shortages DEA Scheduling Propofol FDA Safe Use Initiative FDA Operating Room Fires FDA Opioids FDA Network of Experts FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) USP - US Pharmacopeia Compounding NIH Interagency Pain Research Coordinating Committee NIH: Funding, Indirect Costs, Indirect Grants, Overhead Agency for Healthcare Research and Quality (AHRQ) funding Long COVID research 21st Century Cures Initiative Out of Network/Out of Network Payment Network Adequacy Pre-authorization; prior authorization Insurance reform, shared savings, insurer accountability Affordable Care Act reform efforts Provider Nondiscrimination Change Healthcare, Change Healthcare data breach HR 292 Lorna Breen Reauthorization H.R. 3178, SAVE Healthcare Workers Act: To protect hospital personnel from violence, and for other purposes Maternal Mortality/Maternal Care Deserts Blood management 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care S. 2759/H.R. 5283, the Healthcare Workforce Resilience Act, Exemption for Physicians from New H-1B Visa Policy and $100,000 Fee Medical journal fees No Surprises Act (NSA) - H.R.4710 / S. 2420, the No Surprises Enforcement Act H.R. 3164, the Ensuring Community Access to Pharmacist Services Act Advance Premium Tax Credits (APTCs) Federal regulation of commercial health insurance companies One Big Beautiful Bill (OBBB) Commercial payer/payment H.R.7961: H-1Bs for Physicians and the Healthcare Workforce Act S.3822: Breaking Up Big Medicine Act H.R. 4681: Specialty Physicians Advancing Rural Care (SPARC) Act Low-carbon anesthesia OMB Proposed Rule on federal funding / grants U.S. Departments of State and Homeland Security Visa delays Venezuelan patients Pain management in C-sections
Veterans: Veterans Affairs Advance Practice Registered Nurses HR 3944, Mil Con VA: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act of 2026 VA Physician/Provider Hiring Federal Supremacy Initiative (National Standards of Practice): reduction in patient safety standard Defense Health Agency (DHA): Physician-led care and scope of practice VHA Directive 1123, National Anesthesia Program/Safe Anesthesia Standards in the VA Defense Health Agency anesthesia policy VA Sterile Processing H.R. 8469: Fiscal 2027 MilCon-VA Funding
Government entities reported: Centers For Medicare and Medicaid Services (CMS)
Executive Office of the President (EOP)
Government Accountability Office (GAO)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
Agency for Healthcare Research & Quality (AHRQ)
Centers For Disease Control & Prevention (CDC)
Defense, Dept of (DOD)
Drug Enforcement Administration (DEA)
Federal Trade Commission (FTC)
Food & Drug Administration (FDA)
Justice, Dept of (DOJ)
Natl Institutes of Health (NIH)
Occupational Safety & Health Administration (OSHA)
Office of Management & Budget (OMB)
Veterans Affairs, Dept of (VA)
White House Office
Reported filing-period amount: $270,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗VERTEX PHARMACEUTICALS INCORPORATED
Registrant: VERTEX PHARMACEUTICALS INCORPORATED
2nd Quarter (Apr 1 - June 30)
Jul 16, 2026
Reported lobbying issue
Health Issues: Federal policies impacting pharmaceutical development, approval, and reimbursement; Copay accumulators and maximizers, H.R. 6423/S. 864 - HELP Copays Act; Alternative Funding Programs; Unmet medical need in acute pain; Barriers to patient access of non-opioid pain medicines; General education about kidney disease, including APOL-1 and H.R. 1518 - New Era of Preventing End-Stage Kidney Disease; Cystic Fibrosis; Sickle cell disease; Innovations in Type 1 diabetes treatments.
Medicare/Medicaid: Unmet medical need in acute pain; H.R. 1227/S. 475 - The Alternatives to PAIN Act; Implementation of Public Law No: 117-328 sec. 4135 NO PAIN Act; Medically necessary fertility treatments for patients undergoing fully myeloablative conditioning; CMMI demo focusing on sickle cell disease; Drug Pricing Policies including Most Favored Nation policy proposals.
Taxation/Internal Revenue Code: Corporate tax reform; H.R. 1414 - Cameron's Law, Preservation of Orphan Drug Tax Credit.
Budget/Appropriations: Education about non-opioid pain therapies and patient access to non-opioid medicines, updates on coverage progress at the VHA and CMS.
Veterans: Issues related to veteran's access to non-opioid alternatives and implementation of report language in the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37).
Defense: Issues related to the Defense Health Agency and service member access to non-opioid alternatives, including reinstating the DHA Benefits Advisory Panel and the structured formulary management process.
District of Columbia: Issues related to Sec. 232 pharmaceutical tariffs, onshoring active pharmaceutical ingredients (API), and supply chain disruptions for products related to the opioid public health emergency.
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Centers For Medicare and Medicaid Services (CMS)
Congressional Budget Office (CBO)
Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
Office of Management & Budget (OMB)
Vice President of the U.S.
White House Office
Commerce, Dept of (DOC)
Reported filing-period amount: $1,200,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗PRIME THERAPEUTICS
Registrant: PRIME THERAPEUTICS
2nd Quarter (Apr 1 - June 30)
Jul 16, 2026
Reported lobbying issue
Health Issues: H.R. 7148 (now Public Law 119-75) The Consolidated Appropriations Act provisions regulating pharmacy benefit manager practices S. 2355 Patients Deserve Price Tags Act provisions related to drug price transparency and patient transparency tools S. 3822 Break Up Big Medicine Act provisions related to insurer/PBM ownership or pharmacies S. 1954/HR 5526 The Biosimilar Red Tape Elimination Act - provisions related to interchangeability of biosimilars Department of Labors Notice of Proposed Rulemaking, Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure (RIN 1210-AB37) H.R.9393 Lower Costs, More Transparency Act of 2026
Medicare/Medicaid: H.R. 8143 Ensuring Access to Lower Cost Medicines for Seniors Act of 2026 provisions related to formulary placement of certain drugs. H.R. 7148 (now Public Law 119-75) The Consolidated Appropriations Act provisions regulating pharmacy benefit manager practices H.R. 1227, Alternatives to PAIN Act requirements related to formulary Tierring and prior authorization in Medicare Part D for non-opioid pain medications.
Government entities reported: HOUSE OF REPRESENTATIVES
Labor, Dept of (DOL)
SENATE
Reported filing-period amount: $100,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗VERTEX PHARMACEUTICALS INCORPORATED
Registrant: MARSHALL & POPP, LLC
2nd Quarter (Apr 1 - June 30)
Jul 9, 2026
Reported lobbying issue
Medicare/Medicaid: Issues related to pain management, including S.475/H.R. 1227 - Alternatives to PAIN Act. Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to FDA regulation of pharmaceuticals.
Trade (domestic/foreign): Issues related to tariff and trade policy.
Government entities reported: Centers For Medicare and Medicaid Services (CMS)
HOUSE OF REPRESENTATIVES
SENATE
White House Office
Natl Economic Council (NEC)
Reported filing-period amount: $60,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗AMERICAN PSYCHIATRIC ASSOCIATION
Registrant: AMERICAN PSYCHIATRIC ASSOCIATION
1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026
Reported lobbying issue
Budget/Appropriations: Fiscal Year 2026 (FY2026) Departments of Labor, Health and Human Services, Education, and Related Agencies appropriations bill Fiscal Year 2027 (FY2027) Departments of Labor, Health and Human Services, Education, and Related Agencies appropriations bill
Health Issues: H.R.1096 - HOPE and Mental Wellbeing Act of 2025 H.R. 929/S. 266 - Lorna Breen Health Care Provider Protection Reauthorization H.R. 593 - Strengthening Pathways to Health Professions Act H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act H.R. 1153 - Rural America Health Corps Act H.R. 1227/S. 475 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 1735/S. 779 - EARLY Minds Act H.R. 1448 - PEER for Mental Health Act H.R. 1585/S. 709 - Conrad State 30 and Physician Access Reauthorization Act H.R. 1909/S. 2621 - Preventing Maternal Deaths Reauthorization Act of 2025 H.R. 957 - Parity Enforcement Act H.R. 2509/S. 931 - COMPLETE Care Act H.R. 4206/S. 1261 - CONNECT for Health Act H.R. 1305 - Improving Measurements for Loneliness and Isolation Act H.R. 1902 - Helping Emergency Responders Overcome (HERO) Act H.R. 2223 - Building Capacity for Care Act H.R. 2586 - Reentry Act of 2025 H.R. 3884/S.2011 - Telemental Health Care Access Act of 2025 H.R. 3266/S.1673 - Mental Health Infrastructure Improvement Act of 2025 Mental Health Matters Act H.R. 4619 - Medicare Mental Health Inpatient Equity Act S. 1062 - Suicide Prevention Act H.R. 912 - 9-8-8 Lifeline Cybersecurity Act H.R. 2587 - Youth Mental Health Research Act H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025 H.R. 2630 - Youth Suicide Prevention Research Act H.R. 3655 - STAR Plus Scholarship Act H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025 H.R. 3885/S.3989 - Community TEAMS Act H.R. 1867 - To amend title XVIII of the Social Security Act to remove in-person requirements under Medicare for mental health services furnished through telehealth and telecommunications technology H.R. 3164 - Ensuring Community Access to Pharmacist Services (ECAPS) Act H.R. 4681/S. 1379 - Specialty Physicians Advancing Rural Care (SPARC) Act H.R. 4723/S. 2446 - Mental Health for Latinos Act Conversations with Congressional offices on Teaching Health Center Graduate Medical Education (THCGME) H.R.3505 - Barriers to Suicide Act Letters to Congress to extend the enhanced premium tax credits H.R.6249 - Addressing Addiction After Disasters Act H.R.7394/S.3783 - Mental Health Career Promotion Act H.R. 5074 - Protecting Young Minds Online Act H.R. 5434/S. 2826 - 988 LGBTQ+ Youth Access Act H.R.5509 /S.2903 - Safe Step Act H.R. 5557 - Mental Health Services for Students Act H.R.1197 - PREEMIE Reauthorization Act of 2025 H.R. 3514/S.1816 - Improving Seniors Timely Access to Care Act H.Res.792 - Youth Mental Health Day and Suicide Prevention Day Resolution H.R.5725 - Mental Health Crisis Response Act of 2025 H.R.5706 - Mental Health Emergency Responder Act S. 3064 - Relief of Chronic Pain Act H.R. 6226 - Latino Youth Mental Health Empowerment Act H.R. 5482 - Prevent Youth Suicide Act H.R.6672 - Mental Health Professionals Workforce Shortage Loan Repayment Act Letter to Letter to Department of Labor, Department of Health and Human Services, and Department of Treasury regarding mental health parity enforcement H.R. 3492 - Protect Children's Innocence Act H.R. 498 - Do No Harm in Medicaid Act H.R. 6817/ S. 1056 - Home-Based Telemental Health Care Act Communication with Congressional offices on SAMHSA grant terminations Input on Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) modernization Communication with Congressional offices on ghost networks S. 3486 - Expand the Behavioral Health Workforce Now Act H.R.7324/S. 683 - More Behavioral Health Providers Act H.R. 786/S. 1460 - Preserving Patient Access to Accountable Care Act H.R. 4331 - Access to Claims Data Act H.R.5281 - REAL Health Providers Act H.R.7875 - Providing Opportunities for Individuals in Need of Treatment and Support (POINTS) Act Response to HHS proposed rule on nondiscrimination on the basis of disability Letter to Congress on Agency for Healthcare Research and Quality (AHRQ) funding H.R. 6396 - Kid PROOF Act H.R. 6468 - Rural Residency Planning and Development Act of 2025 H.R. 8234 - Save Money, Save Lives Act H.R.7092 - RAYS Act H.R.7787 - Mental Health Workforce Act Letter in support of funding for gun violence prevention research at CDC, NIH and NIJ. S.4076 - Removing Medicare Mental Health Inpatient Limitations Act of 2026 Letter supporting funding for Maternal Mental Health and Substance Use Disorder Programs (MMHSUD) and National Maternal Mental Health Hotline. H.R. 5629 - To provide that the final rule of the Department of Health and Human Services titled Medications for the Treatment of Opioid Use Disorder except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect H.R. 7994 - The HERO Act
Veterans: H.R. 1107 - Protecting Veteran Access to Telemedicine Services Act H.R. 1987/ S. 926 - Saving Our Veterans Lives Act Support for VA physician exemptions to return to office H.R. 3863 - VA Mental Health Outreach and Engagement Act H.R. 4837 - Written Informed Consent Act Get Justice-Involved Veterans Behavioral Assistance and Care for Key Health Outcomes to Maintain Empowerment (BACK HOME) Act
Medicare/Medicaid: Letter to CMS outlining recommendations for the Medicaid Community Engagement Provisions of H.R.1 Letter to CMS regarding Medicaid and CHIP funding for gender affirming care proposed rule Letter to CMS regarding conditions of participation for gender affirming care proposed rule Response to CMS Medicare Advantage and Medicare Part D 2027 proposed rule Letter to CMS regarding hospital signage guidance Letter to CMS regarding Patient Protection and Affordable Care Act Benefit and Payment Parameters 2027 proposed rule Letter to CMS regarding support for Suicide Safety Planning, and The Collaborative Care Model
Education: H.R. 2028/ S. 942 - Resident Education Deferred Interest Act (REDI Act) Letter to Department of Education to preserve federal loan exception that allows medical students and other health professions to borrow additional Unsubsidized Direct loans Letter to Department of Education regarding proposed amendments to federal student loan limits Letter supporting funding for Mental Health Services Professional Demonstration (MHSP) and School-Based Mental Health Services (SBMH) grant programs
Immigration: Letter to DHS Secretary regarding physician J-1 visas Letter to DHS Secretary for physician exemption to H-1B visa fee H.R. 7961 - H-1Bs for Physicians and the Healthcare Workforce Act
Medical/Disease Research/Clinical Labs: APA Letter to the CDC on the extension of the Maternal Mortality Review Information Application
Government entities reported: Executive Office of the President (EOP)
HOUSE OF REPRESENTATIVES
SENATE
Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
Labor, Dept of (DOL)
Substance Abuse & Mental Health Services Administration (SAMHSA)
Treasury, Dept of
Veterans Affairs, Dept of (VA)
Centers For Medicare and Medicaid Services (CMS)
Education, Dept of
Homeland Security, Dept of (DHS)
Centers For Disease Control & Prevention (CDC)
Reported filing-period amount: $205,809
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗VERTEX PHARMACEUTICALS INCORPORATED
Registrant: AVENUE SOLUTIONS
1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026
Reported lobbying issue
Health Issues: Monitor issues related to 340b; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)
Medicare/Medicaid: H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $60,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗VERTEX PHARMACEUTICALS INCORPORATED
Registrant: CGCN GROUP, LLC
1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026
Reported lobbying issue
Health Issues: Access to innovative non-opioid medicines.
Medicare/Medicaid: Access to innovative non-opioid medicines; Alternatives to PAIN, H.R. 1227; Alternatives to PAIN, S. 475.
Government entities reported: Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
White House Office
Reported filing-period amount: $80,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS
Registrant: AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS
1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026
Reported lobbying issue
Insurance: Support for the Dental and Optometric Care (DOC) Access Act (HR 1521), which would prohibit dental and vision plans from capping fees on non-covered services Support for the Improving Dental Administration Act (HR 7931), which would apply state dental insurance laws to ERISA dental plans operating in that state. Support for reintroduction of the Ensuring Lasting Smiles Act (S 1677/HR 3277), which would require health insurers to cover treatment, including dental, for patients with congenital craniofacial anomalies.
Education: Support for the Resident Education Deferred (REDI) Act (HR 2028/S 942), which would allow physicians and dentists to defer their student loans interest free during residency. Comments on the Reimagining and Improving Student Education Notice of Proposed Rulemaking; RIN 1840-AD98
Medicare/Medicaid: Support for legislative efforts to provide long term reform to the Medicare physician payment system as well as repeal the 2.5 precent efficiency cut scheduled for CY 2026. Comments in response to the proposed rule, Patient Protection and Affordable Care Act (ACA); Notice of Benefit and Payment Parameters for 2027 that opposes reinstating the prohibition on non-pediatric dental services as an essential health benefit.
Health Issues: -Support for the RAPID Reserve Act (S 2062/HR 3955), which aims to address drug shortages by awarding federal contracts to American-based manufacturers of generic drugs to encourage domestic production of these critical medications as well as incentivize them to increase their reserves in preparation for possible future public health threats or supply chain challenges and ramp up their production capacity if necessary to proactively prevent shortages. -Support for the Mapping Americas Pharmaceutical Supply or MAPS Act (S 1784/HR 4191), which seeks conduct a risk assessment and supply chain map of all essential medicines to help identify vulnerabilities and potential national security risks. -Support for the Drug Shortages Prevention Act (S 2665), which would have required manufacturers to notify the FDA of heightened demand for crucial medicines that could lead to shortages -Support for the reintroduction of the following bill from the 118th Congress: The Drug Shortages Prevention and Quality Improvement Act, which aimed to implement reimbursement models to incentivize the production of generic injectables and extend expiration dates for lifesaving medications -Comments in response to the notice of proposed rulemaking (ANPRM) Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals. -Encouraging congressional assistance to seek information from the Defense Health Agency, which administers the Tricare program, on the rates used to reimburse participating providers in the TRICARE Active Duty Dental Program (ADDP). -Support for FY 2027 appropriations for the Dr. Lorna Breen Health Care Provider Protection Act. -Support for the Alternatives to Prevent Addiction in the Nation Act (H.R. 1227), which would reduce cost-sharing and prohibits the imposition of certain utilization requirements under the Medicare prescription drug benefit for certain non-opioid pain management drugs. -Urging CMS to communicate to Part D plan sponsors about the clinical importance of FDA-approved, clinically appropriate non-opioid acute pain treatment options and encourage appropriate formulary coverage ensuring beneficiary access to such approaches.
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Education, Dept of
Centers For Medicare and Medicaid Services (CMS)
Defense, Dept of (DOD)
Reported filing-period amount: $50,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗AMERICAN ASSOCIATION OF NURSE PRACTITIONERS
Registrant: AMERICAN ASSOCIATION OF NURSE PRACTITIONERS
1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026
Reported lobbying issue
Health Issues: H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act S. 1599 - Midwives for Maximizing Optimal Maternity Services (MOMS) Act S. 131/H.R. 392 - Providing Real-world Education and Clinical Experience by Precepting Tomorrows (PRECEPT) Nurses Act H.R. 4564 - Dillons Law H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 3435/H.R. 6607 - Future Advancement of Academic Nursing (FAAN) Act H.R. 1627 - Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act H.R. 2319/S. 1157 - the Women and Lung Cancer Research and Preventive Services Act of 2025 S. 1261/H.R. 4206 - CONNECT for Health Act for 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act (Restore Act) H.Res. 389/S.Res. 206 - Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2025. S. 1482 - National Nursing Workforce Center Act of 2025 H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 1300 - Prostate-Specific Antigen (PSA) Screening for High-risk Insured Men (HIM) Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 5629 - To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect. H.R. 7787 - Mental Health Workforce Act S. 4186/H.R. 8089 - Perinatal Workforce Act H.R. 7973 - Momnibus Act S. 3707/H.R. 7279 - Nurse Faculty Shortage Reduction Act. H.R. 7602 - State of Men's Health Act Chronic Care Management Improvement Act Affordability of health insurance coverage Tobacco prevention Hospice certification and recertification Immunization policies Primary and Behavioral Health Care Access Act Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Health plan coverage and program requirements, including provider non-discrimination, network adequacy and prior authorization Nursing faculty and workforce shortage Nursing education Include nurses, APRNs, and nursing students in all national public health plans Rural health care issues, including rural workforce and reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic Use of telehealth to prescribe controlled substances under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 [Public Law No: 110-425] Site specific restrictions on providers under DEA controlled substances policy Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records
Budget/Appropriations: H.R. 7148 - Consolidated Appropriations Act, 2026 [P.L. No. 119-75] H.R. 929/S. 266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act Funding for Fiscal Year 2027 for Title VIII Nursing Workforce Development Programs Funding for Fiscal Year 2027 for the National Institute of Nursing Research H.R. 5371 - Continuing Appropriations and Extensions Act, 2026 S. 2882 - Continuing Appropriations and Extensions and Other Matters Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] Funding for Fiscal Year 2026 for Title VIII Nursing Workforce Development Programs Funding for Fiscal Year 2026 for the National Institute of Nursing Research H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. Issues pertaining to the Department of Education proposal for the professional degree designation of federal student loans Funding for DCD Environmental Health Laboratory for childrens health Support funding for the National Health Service Corps Removal of burdensome Medicare requirements pertaining to nurse practitioners
Government Issues: H.R. 4122/S. 2167 - Health Care for Energy Workers Act H.R. 3170/S. 3296 - The Improving Access to Workers Compensation for Injured Federal Workers Act Provider neutral language in federal forms, documents and surveys
Medicare/Medicaid: H.R. 5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 H.R. 5217 - Rural Behavioral Health Improvement Act of 2025 H.R. 3684 - Save Americas Rural Hospitals Act S. 1941 - Cure Hepatitis C Act of 2025 H.R. 5081/S. 2709 - Telehealth Modernization Act H.R. 3108/S. 1535 - Rural Patient Monitoring Access Act H.R. 1616/S. 1805 - Promoting Access to Diabetic Shoes Act S. 717/H.R. 6894 - Increasing Access to Quality Cardiac Rehabilitation Care Act H.R. 1317/S. 575 - Improving Care and Access to Nurses (ICAN) Act H.R. 4773/S. 3350 - ACO Assignment Improvement Act of 2025 H.R. 6199/S. 3934 - Medical Nutrition Therapy Act of 2025 H.R. 2509/S. 931 - Connecting Our Medical Providers with Links to Expand Tailored and Effective Care (COMPLETE Care) Act H.R. 2586 - Reentry Act of 2025 H.R. 842/S. 339 - the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 683/H.R. 7324 - More Behavioral Health Providers Act S. 1261/H.R. 4206 - CONNECT for Health Act of 2025 H.R. 2172/S. 1058 - Preserving Patient Access to Home Infusion Act H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 1227/S. 475 - the Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act H.R. 2531/S. 1232 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 7787 - Mental Health Workforce Act H.R. 7106 - Enhancing Skilled Nursing Facilities Act H.R. 7973 - Momnibus Act Hospice certification and recertification Skilled nursing facility admitting examination and assessment requirements Reducing regulatory burdens, including those relating to Medicare Conditions of Participation Medicare provider reimbursement Inclusion of NPs in the HPSA bonus program for clinicians practicing in primary care HPSAs Medicaid reform Issues related to Medicare Part B reform Issues related to enhancing access to care at home in rural and underserved communities Public health and nursing workforce infrastructure Telehealth, remote patient monitoring and other forms of health technology Primary care payment reform Documentation of medical records Medication-Assisted Treatment (MATs) Issues relating to the mental and substance use disorder workforce Opioid epidemic
Veterans: H.R. 2234 - Ensuring Veterans Timely Access to Anesthesia Care Act Advanced Practice Nursing full practice authority in the Veterans Health Administration Use of non-opioid therapies in the VA
Taxation/Internal Revenue Code: H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] H.R. 3145/S. 1548 - Nurse Corp Tax Parity Act Taxation of non-profit organizations
Education: H.R. 1 - One Big Beautiful Bill Act [P.L. No. 119-21] S. 1874/H.R. 3593 - Title VIII Nursing Workforce Reauthorization Act of 2025 Issues pertaining to the Department of Education proposal for the professional degree designation of federal student loans
Defense: H.J.Res.149 - Recognizing the 125th anniversary of the Army Nurse Corps, expressing gratitude for members of the Army Nurse Corps for their service to the Nation, and for other purposes. S.Con.Res.27 - A concurrent resolution celebrating the 125th Anniversary of the Army Nurse Corps
Government entities reported: Centers For Medicare and Medicaid Services (CMS)
Drug Enforcement Administration (DEA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
White House Office
Labor, Dept of (DOL)
Veterans Affairs, Dept of (VA)
Education, Dept of
Office of Management & Budget (OMB)
Reported filing-period amount: $400,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗PRIME THERAPEUTICS
Registrant: PRIME THERAPEUTICS
1st Quarter (Jan 1 - Mar 31)
Apr 20, 2026
Reported lobbying issue
Health Issues: H.R. 7148 (now Public Law 119-75) The Consolidated Appropriations Act provisions regulating pharmacy benefit manager practices S. 2355 Patients Deserve Price Tags Act provisions related to drug price transparency and patient transparency tools S. 3822, Break Up Big Medicine Act provisions related to insurer/PBM ownership or pharmacies S. 1954/HR 5526 The Biosimilar Red Tape Elimination Act -provisions related to interchangeability of biosimilars Department of Labors Notice of Proposed Rulemaking, Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure (RIN 1210-AB37).
Medicare/Medicaid: H.R. 8143 Ensuring Access to Lower Cost Medicines for Seniors Act of 2026 provisions related to formulary placement of certain drugs. H.R. 7148 (now Public Law 119-75) The Consolidated Appropriations Act provisions regulating pharmacy benefit manager practices H.R. 1227, Alternatives to PAIN Act requirements related to formulary Tierring and prior authorization in Medicare Part D for non-opioid pain medications.
Government entities reported: HOUSE OF REPRESENTATIVES
Labor, Dept of (DOL)
SENATE
Reported filing-period amount: $120,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗VERTEX PHARMACEUTICALS
Registrant: TIBER CREEK GROUP
1st Quarter (Jan 1 - Mar 31)
Apr 19, 2026
Reported lobbying issue
Health Issues: Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.
Defense: Issues related to coverage of opioid alternatives.
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Reported filing-period amount: $60,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗VERTEX PHARMACEUTICALS INCORPORATED
Registrant: VERTEX PHARMACEUTICALS INCORPORATED
1st Quarter (Jan 1 - Mar 31)
Apr 17, 2026
Reported lobbying issue
Health Issues: Federal policies impacting pharmaceutical development, approval, and reimbursement; Copay accumulators and maximizers, H.R. 6423/S. 864 - HELP Copays Act; Alternative Funding Programs; Unmet medical need in acute pain; Barriers to patient access of non-opioid pain medicines; General education about kidney disease, including APOL-1 and H.R. 1518 - New Era of Preventing End-Stage Kidney Disease; Cystic Fibrosis; Sickle cell disease; Innovations in Type 1 diabetes treatments.
Medicare/Medicaid: Unmet medical need in acute pain; H.R. 1227/S. 475 - The Alternatives to PAIN Act; Implementation of Public Law No: 117-328 sec. 4135 NO PAIN Act; Medically necessary fertility treatments for patients undergoing fully myeloablative conditioning; CMMI demo focusing on sickle cell disease; Drug Pricing Policies including Most Favored Nation policy proposals.
Taxation/Internal Revenue Code: Corporate tax reform; H.R. 1414 - Cameron's Law, Preservation of Orphan Drug Tax Credit.
Budget/Appropriations: Education about non-opioid pain therapies and patient access to non-opioid medicines, updates on coverage progress at the VHA and CMS.
Trade (domestic/foreign): Intellectual property reforms to address unfair trade practices in Argentina and Russia.
Veterans: Issues related to veteran's access to non-opioid alternatives and implementation of report language in the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37).
Defense: Issues related to the Defense Health Agency and service member access to non-opioid alternatives, including reinstating the DHA Benefits Advisory Panel and the structured formulary management process.
Government entities reported: HOUSE OF REPRESENTATIVES
SENATE
Centers For Medicare and Medicaid Services (CMS)
Congressional Budget Office (CBO)
Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
Office of Management & Budget (OMB)
Vice President of the U.S.
White House Office
U.S. Trade Representative (USTR)
Reported filing-period amount: $1,140,000
This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.
View official LDA filing ↗Showing the 25 most recent matching disclosures.